Hello and Welcome to Patientsville.com, Your Source for all EMSAM information. We are dedicated to provide You with EMSAM safety information. Learn about EMSAM serious adverse events reported to Food and Drug Administration (FDA).

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Health Expert

Do You Have a Question about Your Health?

We will help You understand Your condition and Feel better! Ask Our Health Experts!

Private, Confidential and Discreet

EMSAM Safety Reports

Total EMSAM reports: 166.
EMSAM FDA safety alerts: No.
Reported deaths: 5    Reported hospitalizations: 32.
Take EMSAM Side Effects Survey or Share Your EMSAM Story. Read More Here.

Showing 1-75 of 166 Next >

Consumer or non-health professional from UNITED STATES reported EMSAM problem on Aug 28, 2007. Female patient, weighting 140.0 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: disorientation, insomnia, nausea. EMSAM dosage: 9 MILLIGRAM, 1/1 DAY. During the same period patient was treated with TRANSDERM SCOP. Patient recovered.

EMSAM problem was reported by a Physician from UNITED STATES on Aug 21, 2007. Male patient, 35 years of age, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: cervical vertebral fracture, convulsion, fall. EMSAM dosage: 6 MILLIGRAM, TD. During the same period patient was treated with ABILIFY. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported EMSAM problem on Aug 27, 2007. Male patient, 29 years of age, was diagnosed with bipolar disorder and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: completed suicide, gun shot wound, head injury. EMSAM dosage: 6 MILLIGRAM, 1 DAY;. During the same period patient was treated with LAMICTAL. Patient died on 08/01/2007.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Male patient was diagnosed with depression and was treated with EMSAM. EMSAM dosage: 6 MILLIGRAM, 1/24 HOUR , TD. During the same period patient was treated with CYMBALTA, IMDUR, ACTOS, CRESTOR, EXCEDRIN, FUROSEMIDE, NITROQUICK, PERCOCET. Patient died.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on Aug 24, 2007. Male patient, 73 years of age, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, palpitations. EMSAM dosage: unknown. During the same period patient was treated with NORVASC, LIPITOR, ZETIA, ALTACE, HYDROCHLOROTHIAZIDE, KLONOPIN, NEXIUM, TRAZODONE. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, 57 years of age, weighting 114.6 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. During the same period patient was treated with XANAX, ESTROGEN, KLONOPIN, VAGIFEM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 06, 2007. Female patient, 52 years of age, weighting 130.1 lb, was diagnosed with depression, thyroid disorder, blood pressure, anxiety, pain and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: dermatitis contact, irritability, muscle spasms, tremor. EMSAM dosage: 2 6MG/24HR PATCHES/DAY. HAD USED 9MG/24 HR PATCHES=NDC # 39506-044-01 LOT # 6P0025 EXP DATE 3/08. During the same period patient was treated with SYNTHROID, PREMARIN, HYDROCHLOROTHIAZIDE, CLONAZEPAM, VICODIN, ROBAXIN, BENADRYL, VALSARTAN. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Female patient, weighting 132.3 lb, was diagnosed with anxiety, depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: pruritus, rash, vomiting. EMSAM dosage: unknown. During the same period patient was treated with BUSPAR, NEURONTIN, COMPAZINE, CLONAZEPAM, HYDROCORTISONE, LEXAPRO, XANAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 11, 2007. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: agitation, anxiety, chest discomfort, headache, insomnia, palpitations, urticaria, weight increased. EMSAM dosage: INITIAL DOSE 6MG/24HR, INCREASED TO 9MG/24HR NDC 39506-033-11 LOT 6P0045 EXP APR08. During the same period patient was treated with KLONOPIN, AMBIEN, LEVOXYL, NORCO, GABAPENTIN, LEVOTHYROXINE, LISINOPRIL, HYDROCODONE TARTRATE. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2007. Female patient, 27 years of age, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. During the same period patient was treated with DOXYCYCLINE. Patient recovered.

Physician from UNITED STATES reported EMSAM problem on July 11, 2007. Female patient, 68 years of age, weighting 154.3 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: anxiety, depression. EMSAM dosage: unknown. During the same period patient was treated with NEXIUM, FEXOFENADINE, CRESTOR, LORAZEPAM, ADVAIR DISKUS, MICARDIS, MUCINEX. Patient recovered.

EMSAM problem was reported by a Physician from UNITED STATES on July 23, 2007. Female patient, 35 years of age, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, SEROQUEL, ABILIFY, SYNTHROID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on May 30, 2007. Female patient, weighting 125.7 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: agitation, dizziness, feeling abnormal. EMSAM dosage: unknown. During the same period patient was treated with LORAZEPAM. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Female patient, 87 years of age, weighting 119.0 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: aggression, anxiety, crying, hostility, personality change, restlessness. EMSAM dosage: DOSE INCREASED TO 9 MG WHILE HOSP. IN MAY-07. During the same period patient was treated with ASPIRIN, CALCIUM, SYNTHROID. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on Aug 02, 2007. Female patient, 58 years of age, weighting 125.7 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: anorexia, application site erythema, blood pressure increased, crying, insomnia. EMSAM dosage: unknown. During the same period patient was treated with FIBER MATE. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Male patient, weighting 160.9 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash. EMSAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 08, 2007. Female patient, 62 years of age, weighting 108.0 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: EMSAM 6MG/24HOURS PATCH FOR 12 HOURS/DAY INSTEAD OF 24 HOURS. During the same period patient was treated with VALIUM. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2007. Female patient, weighting 130.1 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, headache, musculoskeletal stiffness, nausea. EMSAM dosage: unknown. During the same period patient was treated with LOTENSIN, PHENERGAN, FIORINAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 12, 2007. Female patient, weighting 145.5 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. During the same period patient was treated with KLONOPIN, SEROQUEL, ENCORTON. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Female patient, 47 years of age, weighting 141.1 lb, was diagnosed with bipolar disorder and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: arthralgia, insomnia, mania, muscular weakness, musculoskeletal pain, nervousness, tremor. EMSAM dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, LAMICTAL, ESTROGEN, KLONOPIN, SEROQUEL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 13, 2007. Male patient, weighting 229.3 lb, was diagnosed with depression, panic attack, anxiety and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. During the same period patient was treated with INDERAL, ZESTRIL, LAMICTAL, LITHIUM CARBONATE, XANAX, SYNTHROID. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Male patient, weighting 260.1 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: back pain. EMSAM dosage: unknown. During the same period patient was treated with XANAX, ATENOLOL, TRAZODONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 03, 2007. Male patient, 64 years of age, weighting 169.8 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction, oedema peripheral, rash. EMSAM dosage: INCREASED TO 9MG/24H 18-MAY-2007 THEN 12MG/24H 18-JUN-2007. During the same period patient was treated with HYDROCHLOROTHIAZIDE, LIPITOR, VERELAN PM. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2007. Female patient, weighting 169.8 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: rash. EMSAM dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, INDERAL, LIPITOR, SEROQUEL, LORAZEPAM. Patient recovered.

Health Professional from UNITED STATES reported EMSAM problem on June 19, 2007. Female patient, 51 years of age, weighting 145.5 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash. EMSAM dosage: unknown. During the same period patient was treated with ATENOLOL, HYDROCHLOROTHIAZIDE, PROMETRIUM, ALBUTEROL, ACYCLOVIR, ESTROGENIC SUBSTANCE. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Male patient, 66 years of age, weighting 194.0 lb, was diagnosed with depression, anxiety and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: headache, neck pain. EMSAM dosage: unknown. During the same period patient was treated with ASPIRIN, XANAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 20, 2007. Female patient, 52 years of age, weighting 114.6 lb, was diagnosed with major depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site erythema. EMSAM dosage: unknown. During the same period patient was treated with LAMICTAL, ACTONEL, SEROQUEL, ZYRTEC. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 40 years of age, weighting 110.2 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: laceration, syncope. EMSAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 22, 2007. Male patient, 26 years of age, weighting 260.1 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: dysphagia, pain, pharyngeal oedema. EMSAM dosage: unknown. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2007. Female patient, 63 years of age, weighting 119.0 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: anxiety. EMSAM dosage: unknown. During the same period patient was treated with LAMICTAL, KLONOPIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 25, 2007. Female patient, weighting 125.7 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: arthralgia, insomnia, myalgia, nausea. EMSAM dosage: unknown. During the same period patient was treated with KLONOPIN, DOXYCYCLINE. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2007. Female patient, weighting 132.3 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: arthralgia. EMSAM dosage: unknown. During the same period patient was treated with ESTRADIOL, TEMAZEPAM, LAMICTAL, PROPRANOLOL, ALEVE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 25, 2007. Female patient, 61 years of age, weighting 105.8 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: anxiety, application site rash, dizziness, insomnia, oral intake reduced, sexual dysfunction, weight decreased. EMSAM dosage: INIT. 6MG/24HR (LACK OF EFFECT) THEN INCREASED TO 9MG/24HR AND DEVEL OTHER AES.THEN DECREASED.. During the same period patient was treated with LEVOXYL, ADVIL LIQUI, CALCIUM, VITAMIN B CAP, MILK THISTLE, FLAXSEED OIL, HERBALTURE. Patient recovered.

EMSAM problem was reported by a Physician from UNITED STATES on July 31, 2007. Female patient, 25 years of age, was diagnosed with affective disorder and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: rectal haemorrhage. EMSAM dosage: unknown. During the same period patient was treated with DEPAKOTE, XANAX, LAMICTAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported EMSAM problem on June 28, 2007. Female patient, 46 years of age, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: dermatitis contact. EMSAM dosage: unknown. Patient recovered.

EMSAM problem was reported by a Physician from UNITED STATES on June 28, 2007. Female patient, 45 years of age, weighting 110.2 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: headache, musculoskeletal stiffness. EMSAM dosage: unknown. During the same period patient was treated with GEODON. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on June 29, 2007. Male patient, 53 years of age, weighting 299.8 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: erythema, pruritus. EMSAM dosage: unknown. During the same period patient was treated with LIPITOR. Patient recovered.

EMSAM problem was reported by a Physician from UNITED STATES on July 23, 2007. Male patient, 60 years of age, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: crying. EMSAM dosage: unknown. During the same period patient was treated with CELEXA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 03, 2007. Female patient, 36 years of age, weighting 216.1 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: insomnia. EMSAM dosage: unknown. During the same period patient was treated with ATENOLOL, GABAPENTIN, SEROQUEL. Patient recovered.

EMSAM problem was reported by a Physician from UNITED STATES on July 03, 2007. Female patient, 40 years of age, was diagnosed with major depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: oedema peripheral. EMSAM dosage: unknown. During the same period patient was treated with SEROQUEL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 05, 2007. Female patient, weighting 130.1 lb, was diagnosed with depression, anxiety and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: agitation, anorexia, nervousness, weight decreased. EMSAM dosage: unknown. During the same period patient was treated with LEVOXYL, CLONAZEPAM. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2007. Female patient, weighting 264.6 lb, was diagnosed with bipolar disorder and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. During the same period patient was treated with FORADIL, NEXIUM, SINGULAIR, LAMICTAL, LEVOTHYROXINE, TOPAMAX, ZYRTEC, LORAZEPAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 17, 2007. Female patient, 62 years of age, weighting 103.6 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: anorexia, anxiety, blood pressure decreased, dizziness, dry mouth, insomnia, nausea, weight decreased. EMSAM dosage: unknown. During the same period patient was treated with SYNTHROID. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Male patient, 49 years of age, weighting 299.8 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: blister, urticaria. EMSAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 12, 2007. Female patient, weighting 138.9 lb, was diagnosed with depression, menopause and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. During the same period patient was treated with SINGULAIR. Patient recovered.

EMSAM problem was reported by a Physician from UNITED STATES on July 13, 2007. Male patient, 73 years of age, was diagnosed with major depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash. EMSAM dosage: unknown. During the same period patient was treated with KLONOPIN. Patient recovered.

Health Professional from UNITED STATES reported EMSAM problem on Aug 16, 2007. Female patient, 40 years of age, weighting 189.6 lb, was diagnosed with major depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site bruising, gastrooesophageal reflux disease, oesophageal ulcer. EMSAM dosage: unknown. During the same period patient was treated with LORAZEPAM, ASPIRIN, FERROUS SULPHATE, ALTACE, OMEPRAZOLE, METOCLOPRAMIDE, RANITIDINE. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2007. Female patient, 67 years of age, weighting 149.9 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. During the same period patient was treated with LOVASTATIN, IMITREX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 16, 2007. Female patient, weighting 222.7 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: hyperhidrosis, insomnia. EMSAM dosage: unknown. During the same period patient was treated with LAMICTAL, SEROQUEL, ABILIFY, ATENOLOL, TRIAMTERENE, CRESTOR, VIVELLE. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2007. Female patient, weighting 138.9 lb, was diagnosed with major depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: back pain, musculoskeletal pain, neck pain. EMSAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 17, 2007. Female patient, 63 years of age, weighting 174.2 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash. EMSAM dosage: unknown. During the same period patient was treated with LISINOPRIL, PROPRANOLOL, XANAX, AMBIEN, VYTORIN. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2007. Female patient, 56 years of age, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: erythema, fear, feeling hot, feeling jittery, hallucination, visual, headache, hyperhidrosis, insomnia, joint stiffness. EMSAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 18, 2007. Female patient, 29 years of age, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: rash. EMSAM dosage: unknown. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Female patient, 53 years of age, was diagnosed with major depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. During the same period patient was treated with CLONAZEPAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 19, 2007. Female patient, weighting 119.0 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: CURRENT DOSE OF SELIGILINE TRANSDERMAL PATCH IS 9 MG.. During the same period patient was treated with LISINOPRIL, CLONAZEPAM, SEROQUEL, PREVACID. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Female patient, 59 years of age, weighting 200.6 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: fatigue. EMSAM dosage: unknown. During the same period patient was treated with ORENCIA, LAMICTAL, XANAX, AMBIEN, LOTREL, PREDNISONE, ZEGERID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 20, 2007. Female patient, 45 years of age, weighting 160.9 lb, was diagnosed with anxiety, depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: constipation, feeling jittery, irritability, oedema, urinary retention, weight increased. EMSAM dosage: unknown. During the same period patient was treated with WELLBUTRIN, AMBIEN CR, KLONOPIN, CYTOMEL, ALLERGEX. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2007. Female patient, 51 years of age, weighting 116.8 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anxiety, overdose. EMSAM dosage: unknown. During the same period patient was treated with DEPAKOTE ER, LOESTRIN, SIMVASTIN, AMBIEN CR, ZOFRAN, ATIVAN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported EMSAM problem on Aug 07, 2007. Female patient, 74 years of age, weighting 165.3 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site rash. EMSAM dosage: unknown. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2007. Female patient, 34 years of age, weighting 138.9 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: headache, nausea. EMSAM dosage: unknown. During the same period patient was treated with CYMBALTA, BACLOFEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 24, 2007. Female patient, 62 years of age, weighting 123.5 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: anxiety, insomnia. EMSAM dosage: FEB-MARCH 2007 STARTED ON 6MG/24HR;1 MONTH LATER INCR TO 9MG/24HR; 2-3 WEEKS LATER INCR TO 12MG/24HR. During the same period patient was treated with ZOCOR, XANAX, VALTREX, PRILOSEC, CALCIUM, MAGNESIUM SULPHATE, VITAMIN B. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2007. Female patient, weighting 130.1 lb, was diagnosed with depression, anxiety and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: dizziness, dysacusis, fatigue, galactorrhoea, irritability, migraine, muscle spasms, night sweats. EMSAM dosage: unknown. During the same period patient was treated with RELPAX, TOPAMAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 25, 2007. Female patient, weighting 125.7 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: abdominal distension, application site rash, dysgeusia, headache, insomnia, malaise, somnolence, weight increased. EMSAM dosage: unknown. During the same period patient was treated with FISH OIL, LAMICTAL. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2007. Male patient, 55 years of age, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: diarrhoea, nausea. EMSAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 30, 2007. Female patient, 21 years of age, was diagnosed with bipolar disorder and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2007. Female patient, 57 years of age, weighting 114.6 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: agitation, insomnia, irritability. EMSAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on July 31, 2007. Female patient, weighting 138.9 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: anxiety. EMSAM dosage: unknown. During the same period patient was treated with SYNTHROID. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2007. Male patient, 36 years of age, weighting 235.9 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: hyperphagia, libido increased. EMSAM dosage: unknown. During the same period patient was treated with LAMICTAL, TOPAMAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on Aug 01, 2007. Female patient, weighting 209.4 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, pain in extremity. EMSAM dosage: ONE WEEK PRIOR TO REPORTING, DOSE WAS 9MG/24HR. During the same period patient was treated with GABAPENTIN, ATIVAN, AMBIEN. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2007. Female patient, weighting 269.0 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on Aug 03, 2007. Female patient, weighting 147.7 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. During the same period patient was treated with KLONOPIN, DIOVAN, TYLENOL. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2007. Female patient, 55 years of age, weighting 119.0 lb, was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site reaction. EMSAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on Aug 13, 2007. Male patient, 46 years of age, weighting 350.5 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: fatigue. EMSAM dosage: unknown. During the same period patient was treated with VASOTEC, RISPERDAL, ZETIA, LIPITOR, AMBIEN, TOPAMAX. Patient recovered.

EMSAM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 12, 2007. Male patient, 42 years of age, weighting 189.6 lb, was diagnosed with major depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: balance disorder, binocular eye movement disorder, blepharospasm, disorientation, dizziness, dry mouth, erythema, hypertension, mood altered. EMSAM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EMSAM problem on Aug 13, 2007. Female patient, 57 years of age, weighting 198.4 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site scar, hypertrichosis, rash. EMSAM dosage: unknown. During the same period patient was treated with OXYCONTIN, AMBIEN CR, JANUVIA, OXYCODONE, KLONOPIN, ZANAFLEX, SYNTHROID, ZYRTEC. Patient recovered.

Showing 1-75 of 166 Next >

back to top

New! Check out useful Hospital Quality Data! Click on a state to continue:

ALABAMA  ALASKA  AMERICAN SAMOA  ARIZONA  ARKANSAS  CALIFORNIA  COLORADO  CONNECTICUT  DELAWARE  DISTRICT OF COLUMBIA  FEDERATED STATES OF MICRONESIA  FLORIDA  GEORGIA  GUAM  HAWAII  IDAHO  ILLINOIS  INDIANA  IOWA  KANSAS  KENTUCKY  LOUISIANA  MAINE  MARSHALL ISLANDS  MARYLAND  MASSACHUSETTS  MICHIGAN  MINNESOTA  MISSISSIPPI  MISSOURI  MONTANA  NEBRASKA  NEVADA  NEW HAMPSHIRE  NEW JERSEY  NEW MEXICO  NEW YORK  NORTH CAROLINA  NORTH DAKOTA  NORTHERN MARIANA ISLANDS  OHIO  OKLAHOMA  OREGON  PALAU  PENNSYLVANIA  PUERTO RICO  RHODE ISLAND  SOUTH CAROLINA  SOUTH DAKOTA  TENNESSEE  TEXAS  UTAH  VERMONT  VIRGIN ISLANDS  VIRGINIA  WASHINGTON  WEST VIRGINIA  WISCONSIN  WYOMING back to top

Home Care Provider Quality Reports and Home Care Provider Reviews

ALABAMA  ALASKA  AMERICAN SAMOA  ARIZONA  ARKANSAS  CALIFORNIA  COLORADO  CONNECTICUT  DELAWARE  DISTRICT OF COLUMBIA  FEDERATED STATES OF MICRONESIA  FLORIDA  GEORGIA  GUAM  HAWAII  IDAHO  ILLINOIS  INDIANA  IOWA  KANSAS  KENTUCKY  LOUISIANA  MAINE  MARSHALL ISLANDS  MARYLAND  MASSACHUSETTS  MICHIGAN  MINNESOTA  MISSISSIPPI  MISSOURI  MONTANA  NEBRASKA  NEVADA  NEW HAMPSHIRE  NEW JERSEY  NEW MEXICO  NEW YORK  NORTH CAROLINA  NORTH DAKOTA  NORTHERN MARIANA ISLANDS  OHIO  OKLAHOMA  OREGON  PALAU  PENNSYLVANIA  PUERTO RICO  RHODE ISLAND  SOUTH CAROLINA  SOUTH DAKOTA  TENNESSEE  TEXAS  UTAH  VERMONT  VIRGIN ISLANDS  VIRGINIA  WASHINGTON  WEST VIRGINIA  WISCONSIN  WYOMING

back to top

Side Effects can be harmful to Your Health! Check adverse reaction reports for these medication and vaccine side effects:

back to top

Search for additional information about EMSAM here:
Thank you for visiting Patientsville.net. Hope you enjoyed finding information on EMSAM and found answers to EMSAM Questions